Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium
Top Cited Papers
- 1 July 2011
- journal article
- review article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 140 (1), 221-229
- https://doi.org/10.1378/chest.10-2572
Abstract
No abstract availableKeywords
Funding Information
- United Therapeutics Corporation
- Bayer
- Gilead Sciences
- Actelion Pharmaceuticals
This publication has 25 references indexed in Scilit:
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report—2010The Journal of Heart and Lung Transplantation, 2010
- Disease-Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort StudyAmerican Journal of Transplantation, 2009
- International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Radiological versus histological diagnosis in UIP and NSIP: survival implicationsThorax, 2003
- Assessment of survival benefit after lung transplantation by patient diagnosisThe Journal of Heart and Lung Transplantation, 2002
- Nonspecific Interstitial Pneumonia/FibrosisThe American Journal of Surgical Pathology, 1994
- Cryptogenic fibrosing alveolitis: clinical features and their influence on survivalThorax, 1980
- Natural History and Treated Course of Usual and Desquamative Interstitial PneumoniaThe New England Journal of Medicine, 1978
- The prognosis of cryptogenic fibrosing alveolitisThorax, 1972